A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy

Samuel G. Awuah, Yao Rong Zheng, Peter M. Bruno, Michael T. Hemann, Stephen J. Lippard

Research output: Contribution to journal › Article › peer-review

149 Scopus citations

Fingerprint

Dive into the research topics of 'A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology